These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38883758)

  • 1. Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology.
    Applebaum M; Ramesh S; Dyer E; Pomaville M; Doytcheva K; Dolezal J; Kochanny S; Terhaar R; Mehrhoff C; Patel K; Brewer J; Kusswurm B; Naranjo A; Shimada H; Sokol E; Cohn S; George R; Pearson A
    Res Sq; 2024 Jun; ():. PubMed ID: 38883758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence-based morphologic classification and molecular characterization of neuroblastic tumors from digital histopathology.
    Ramesh S; Dyer E; Pomaville M; Doytcheva K; Dolezal J; Kochanny S; Terhaar R; Mehrhoff CJ; Patel K; Brewer J; Kusswurm B; Naranjo A; Shimada H; Cipriani NA; Husain AN; Pytel P; Sokol EA; Cohn SL; George RE; Pearson AT; Applebaum MA
    NPJ Precis Oncol; 2024 Nov; 8(1):255. PubMed ID: 39511421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
    Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated Tumor Count for Mitosis-Karyorrhexis Index Determination in Neuroblastoma Using Whole Slide Image and Qupath, an Image Analytic Software.
    Yu G; Yu C; Xie F; He M
    Pediatr Dev Pathol; 2022; 25(5):526-537. PubMed ID: 35570824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-supervised learning mechanism for identification of eyelid malignant melanoma in pathologic slides with limited annotation.
    Wang L; Jiang Z; Shao A; Liu Z; Gu R; Ge R; Jia G; Wang Y; Ye J
    Front Med (Lausanne); 2022; 9():976467. PubMed ID: 36237543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic information obtained on fine-needle aspirates of primary neuroblastic tumors: Proposal for a cytology prognostic score.
    Klijanienko J; Couturier J; Brisse H; Pierron G; Fréneaux P; Berger F; Maciorowski Z; Sastre-Garau X; Michon J; Schleiermacher G
    Cancer Cytopathol; 2011 Dec; 119(6):411-23. PubMed ID: 21774092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
    Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
    Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
    Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
    Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High ¹²³I-MIBG uptake in neuroblastic tumours indicates unfavourable histopathology.
    Fendler WP; Melzer HI; Walz C; von Schweinitz D; Coppenrath E; Schmid I; Bartenstein P; Pfluger T
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1701-10. PubMed ID: 23857458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
    Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
    Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
    Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
    J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitosis-Karyorrhexis Index evaluation by digital image visual analysis for application of International Neuroblastoma Pathology Classification in FNA biopsy.
    Bhardwaj N; Rohilla M; Trehan A; Bansal D; Kakkar N; Srinivasan R
    Cancer Cytopathol; 2022 Feb; 130(2):128-135. PubMed ID: 34633743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annotation protocol and crowdsourcing multiple instance learning classification of skin histological images: The CR-AI4SkIN dataset.
    Del Amor R; Pérez-Cano J; López-Pérez M; Terradez L; Aneiros-Fernandez J; Morales S; Mateos J; Molina R; Naranjo V
    Artif Intell Med; 2023 Nov; 145():102686. PubMed ID: 37925214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group.
    Teshiba R; Kawano S; Wang LL; He L; Naranjo A; London WB; Seeger RC; Gastier-Foster JM; Look AT; Hogarty MD; Cohn SL; Maris JM; Park JR; Shimada H
    Pediatr Dev Pathol; 2014; 17(6):441-9. PubMed ID: 25207821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYCN gene amplification in patients with neuroblastic tumors.
    Estiar MA; Fazilaty H; Aslanabadi S; Seifi M; Varghaei P; Rezamand A
    Cell Mol Biol (Noisy-le-grand); 2014 Sep; 60(3):23-8. PubMed ID: 25231001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided evaluation of neuroblastoma on whole-slide histology images: Classifying grade of neuroblastic differentiation.
    Kong J; Sertel O; Shimada H; Boyer KL; Saltz JH; Gurcan MN
    Pattern Recognit; 2009 Jun; 42(6):1080-1092. PubMed ID: 28626265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Federated Learning for Decentralized Artificial Intelligence in Melanoma Diagnostics.
    Haggenmüller S; Schmitt M; Krieghoff-Henning E; Hekler A; Maron RC; Wies C; Utikal JS; Meier F; Hobelsberger S; Gellrich FF; Sergon M; Hauschild A; French LE; Heinzerling L; Schlager JG; Ghoreschi K; Schlaak M; Hilke FJ; Poch G; Korsing S; Berking C; Heppt MV; Erdmann M; Haferkamp S; Drexler K; Schadendorf D; Sondermann W; Goebeler M; Schilling B; Kather JN; Fröhling S; Brinker TJ
    JAMA Dermatol; 2024 Mar; 160(3):303-311. PubMed ID: 38324293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours.
    Uccini S; Colarossi C; Scarpino S; Boldrini R; Natali PG; Nicotra MR; Perla FM; Mannarino O; Altavista P; Boglino C; Cappelli CA; Cozzi D; Donfrancesco A; Kokai G; Losty PD; McDowell HP; Dominici C
    Br J Cancer; 2006 Jul; 95(1):49-55. PubMed ID: 16755292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
    Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
    J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.